Skip to main content
. 2020 Jul 22;9(5):596–612. doi: 10.1159/000508809

Table 3.

DRR ≥3 months and ≥6 months for each subclassification model

Low burden (at the time of diagnosis as intermediate-stage HCC) High burden (group A: at the time of diagnosis as intermediate-stage HCC) High burden (group B: progressed from low burden) High burden (group A + B)
Model 1 (up-to-seven criteria)
Child-Pugh A
 DRR ≥3 months 46.4% 39.5% 28.6% 38.7%
 DRR ≥6 months 26.2% 15.1% 7.1% 14.5%
Child-Pugh B
 DRR ≥3 months 56.3% 22.7% 0.0% 22.2%
 DRR ≥6 months 18.8% 9.1% 0.0% 8.7%

Model 2 (five-seven criteria)
Child-Pugh A
 DRR ≥3 months 46.5% 34.7% 23.1% 32.3%
 DRR ≥6 months 24.5% 9.9% 15.4% 11.0%
Child-Pugh B
 DRR ≥3 months 37.1% 24.0% 0.0% 23.1%
 DRR ≥6 months 14.3% 8.0% 0.0% 6.9%

Model 3 (seven lesions criteria)
Child-Pugh A
 DRR ≥3 months 45.8% 34.4% 21.4% 31.4%
 DRR ≥6 months 23.5% 10.0% 14.3% 11.0%
Child-Pugh B
 DRR ≥3 months 37.8% 21.7% 0.0% 20.8%
 DRR ≥6 months 16.2% 4.3% 0.0% 3.6%

DRR, durable response rate; HCC, hepatocellular carcinoma.